National and Kapodistrian University of Athens
Στρεσογόνες επιδράσεις της νεφρικής ανεπάρκειας στα ώριμα ερυθροκύτταρα
Abstract
dc:descriptionEnd stage renal disease (ESRD) patients exhibit a baseline profile of blood modifications, developed around a pathophysiological core of anemia, uremia, inflammation and oxidative stress. There is however, a huge inter-patient variability in numerous measures of red blood cell (RBC) and blood homeostasis, related in part to the administration of widely variable erythropoietin doses. Dialysis therapy, on the other hand, exerts additional stimuli on cells. Haemodiafiltration (HDF) is a renal replacement therapy which is based on the principles of diffusion and convection. It is generally thought to be more effective than conventional haemodialysis (cHD) in eliminating uremic toxins and in improving anemia; however, its effects on red blood cell (RBC) physiological features have not been examined in depth. This study assesses the physiological profile of RBCs in patients with ESRD receiving standard or high doses of recombinant human erythropoietin (rhEPO) as well as the effects of hemodiafiltration versus conventional hemodialysis in hematologic profile and RBC physiology.Blood samples from twenty-eight patients under sustained conventional hemodialysis, responsive, or not to standard rhEPO administration and thirty-two patients under regular HDF or cHD treatment were examined for haematological and RBC-related parameters compared to healthy donors. Red blood cells and plasma were studied for RBC morphology, fragility, hemolysis, redox status, removal signaling, membrane protein composition, and microvesiculation, in repeated paired measurements accomplished before and right after each dialysis session. Acute effects of uremic plasma on RBC features were examined in vitro through reconstitution experiments.Overall, the ESRD RBCs were characterized by pathological levels of shape distortions, surface removal signaling, and membrane exovesiculation, but reduced fragility compared to healthy RBCs. Irreversible transformation of RBCs was found to be a function of baseline Hb concentration. The more toxic uremic context in non-responsive patients compared to rhEPO responders was blunted in part by the antioxidant, anti-hemolytic, and anti-apoptotic effects of high rhEPO doses, and probably, of serum uric acid. A selective lower expression of RBC membrane in complement regulators (CD59, clusterin) and of CD47 “marker-of- self” was detected in non-responders and responders, respectively. Evidence for different short-term dialysis effects and probably for a different erythrocyte vesiculation mechanism in rhEPO responsive compared to non-responsive patients was also revealed. Regarding dialysis therapy effects, HDF-group of patients was characterized by better anemic indexes, improved redox potential and suppressed exovesiculation of blood cells compared to cHD-group pre-dialysis. However, HDF was associated with a temporary but acute, oxidative stress-driven adverse effect on RBCs, reflected by appearance of haemolysis, removal signaling and stomatocytosis.Conclusively, deregulation of RBC homeostasis might involve diverse molecular pathways driving erythrocyte signaling and removal in rhEPO non-responders compared to responsive patients. Moreover, HDF has beneficial “long-term” effects over cHD on ESRD in respect to anemia and RBC physiology. The adverse short-term effects of HDF on postdialysis plasma and RBCs, which are probably associated with the effective clearance of natural antioxidant components from the uremic plasma, strongly suggest the use of a parallel antioxidant therapy during the dialysis session.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2017
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Georgatzakou, Chara
- Γεωργατζάκου, Χαρά
Subjects
dc:subject × 14Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/40826